0

Tempus Cardiology is an AI-powered diagnostic and clinical decision support suite designed to assist healthcare providers in identifying and managing undiagnosed or undertreated cardiovascular conditions. The platform leverages advanced machine learning models, including FDA-cleared ECG-AI algorithms and cardiac MR image analysis tools, alongside clinical EHR data to surface guideline-directed care recommendations. By surfacing timely, point-of-care insights across multi-specialty care pathways, Tempus Cardiology helps clinicians close critical care gaps for conditions such as atrial fibrillation, low ejection fraction, and heart valve diseases.

AI-enabled solutions to help providers close care gaps for patients who may have undiagnosed and undertreated cardiovascular disease

Key features

  • Tempus ECG-AF (FDA 510(k) cleared): detects signs of AF within 12 months from resting 12-lead ECGs in patients 65+ without known AF
  • Tempus ECG-Low EF (FDA 510(k) cleared): detects signs of LVEF of 40% or lower from resting 12-lead ECGs in patients 40+ at risk of heart failure
  • Tempus ECG-MR (listed as FDA-cleared): detects signs of moderate or severe mitral regurgitation in patients 65+ at risk of cardiovascular disease
  • Tempus ECG-PH (listed as FDA-cleared): detects signs of elevated mean pulmonary artery pressure in patients 40+ with symptoms and no known PH
  • Patient filtering: uses EHR integrations and clinical data to find patients eligible under each device's instructions-for-use criteria
  • Care pathway algorithms: 40+ algorithms for care gaps across 15 cardiovascular diseases
  • Tiered EHR notifications: guideline-based alerts in the clinician's workflow, described as designed to reduce alert fatigue
  • Patient Tracking, Patient Lists and hospital dashboards
  • Disease areas in Next: aorta, structural heart, cardiomyopathies, electrophysiology, guideline-directed medical therapy monitoring
  • Tempus Pixel: advanced viewing and automated reporting of cardiac MR images

Strengths

  • Four ECG-AI devices listed as FDA-cleared, with published intended use, training-set sizes and performance figures
  • Care pathway platform covering 15 cardiovascular diseases, built into the EHR workflow
  • Randomized evidence on the site (ALERT cluster randomized trial of automated valve disease alerts)
  • Category III CPT codes +0764T and 0765T apply to assistive algorithmic ECG assessments, as described on the site
  • Designed to work with existing ECG platforms and EHRs

Best for

  • Hospital and health system structural heart or valve program leaders
  • Cardiology and heart failure teams closing care gaps in undertreated patients
  • Health systems adding ECG-based screening for AF, low EF, mitral regurgitation or pulmonary hypertension
  • Academic centers and research groups running studies with Tempus

Integrations

  • Electronic Health Records (EHR) (native, deep, system)
  • ECG Platforms (native, deep, system)

Categories

Features

Add Review

Leave a Reply

Your email address will not be published. Required fields are marked *

Model Performance
Please rate Model Performance
Technique
Please rate Technique
Security
Please rate Security
Value for Money
Please rate Value for Money